NEWS

January 24, 2023

Boost for Clinuvel a skin cancer drug passes phase 2 trials

SYDNEY: Clinuvel has successfully completed a phase two trial on a drug aimed ... read more

January 24, 2023

Nanosonics leads health stocks higher with announcement

MELBOURNE: Shares in Nanosonics closed up 8 per cent on Thursday after the ... read more

January 24, 2023

NSW Premier rejects regional poker machine exception

SYDNEY: Premier Dominic Perrottet has ruled out exempting NSW regional pubs and clubs ... read more

January 24, 2023

Fitch affirms Aristocrat’s ‘BBB-‘ IDR; Outlook stable

NEW YORK: Fitch Ratings has affirmed the Long-Term Issuer Default Ratings (IDRs) of ... read more